{"nct_id":"NCT01192165","title":"Safety and Tolerability Study of GSK1120212, a MEK Inhibitor, in Combination With Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, Pemetrexed + Cisplatin, or Nab-Paclitaxel","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2010-09-14","start_date_type":"ACTUAL","primary_completion_date":"2013-10-07","primary_completion_date_type":"ACTUAL","completion_date":"2013-10-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}